How has been the historical performance of Godavari Bioref.?

Answer:The historical performance of Godavari Bioref. shows a fluctuating trend in key financial metrics over the past three years.

Breakdown:
Godavari Bioref. reported net sales of 1,870.25 Cr in Mar'25, an increase from 1,686.67 Cr in Mar'24 but a decline from 2,014.69 Cr in Mar'23. Total operating income mirrored this trend, reaching 1,870.25 Cr in Mar'25, up from 1,686.67 Cr in Mar'24 but down from 2,014.69 Cr in Mar'23. The raw material cost decreased significantly to 1,242.75 Cr in Mar'25 from 1,533.15 Cr in Mar'24, while total expenditure (excluding depreciation) rose to 1,766.60 Cr in Mar'25 from 1,553.13 Cr in Mar'24. Operating profit (PBDIT) fell to 120.31 Cr in Mar'25 from 147.94 Cr in Mar'24, leading to a profit before tax of -1.54 Cr in Mar'25, a decline from 12.45 Cr in Mar'24 and 31.75 Cr in Mar'23. Consequently, profit after tax dropped to -23.41 Cr in Mar'25 from 12.30 Cr in Mar'24. The company's total assets decreased slightly to 1,955.09 Cr in Mar'25 from 1,991.50 Cr in Mar'24, while total liabilities also fell to 1,955.09 Cr in Mar'25 from 1,991.50 Cr in Mar'24. Cash flow from operating activities was 6.00 Cr in Mar'25, down from 185.00 Cr in Mar'24, indicating a significant decline in operational efficiency. Overall, the financial data reflects a challenging year for Godavari Bioref. with declining profits and cash flow despite some improvements in sales.